$106 | SAVE $19 | Single User
$213 | SAVE $37 | Site License
$319 | SAVE $56 | Enterprise License

Jubilant Life Sciences Limited - Financial and Strategic SWOT Analysis Review

Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
[Lowest Price Guaranteed: $106]

Published by Global Data: 02 Aug 2016 | 13494 | In Stock
Related Topics: Business , Financial , Investment , Life

Introduction

Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Jubilant Life Sciences Limited (Jubilant) is an integrated pharmaceutical and life sciences company that carries out the manufacture and supply of radiopharmaceuticals, allergy therapy products, active pharmaceutical ingredients (APIs), solid dosage formulations, life science chemicals, nutritional products, fine ingredients, advance intermediates and crop science ingredients. It also provides contract manufacturing of sterile injectables and drug discovery and development services. The company caters its products and services to customers across India, North America, Canada, Europe and China. It owns and operates cGMP compliant manufacturing facilities, and research and development centers in India, the US and Canada. Jubilant is headquartered in Noida, Uttar Pradesh, India.

Jubilant Life Sciences Limited Key Recent Developments

May 24, 2016: Jubilant Life Sciences announces board changes

May 24, 2016: Jubiliant life sciences reports Q4 & FY 2016 results

Mar 29, 2016: Jubilant Innovation Receives Upfront Payment and Potential Milestones from Its Investment

Feb 19, 2016: Jubilant Reports Strong Profitability Q3 FY2016 EBITDA at Rs. 310 Crore, UP 62% YOY and PAT at Rs. 117 Crore

Feb 06, 2016: Ministry of Commerce China has reduced the Anti-Dumping Duty on Pyridine from Jubilant to 17.6%

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Section 1 - About the Company 6

    Jubilant Life Sciences Limited - Key Facts 6

    Jubilant Life Sciences Limited - Key Employees 7

    Jubilant Life Sciences Limited - Key Employee Biographies 8

    Jubilant Life Sciences Limited - Major Products and Services 9

    Jubilant Life Sciences Limited - History 11

    Jubilant Life Sciences Limited - Company Statement 17

    Jubilant Life Sciences Limited - Locations And Subsidiaries 18

    Head Office 18

    Other Locations & Subsidiaries 18

    Joint Venture 21

    Section 2 – Company Analysis 22

    Jubilant Life Sciences Limited - Business Description 22

    Jubilant Life Sciences Limited - Corporate Strategy 23

    Jubilant Life Sciences Limited - SWOT Analysis 24

    SWOT Analysis - Overview 24

    Jubilant Life Sciences Limited - Strengths 24

    Strength - Focused Research and Development Activities 24

    Strength - Pharmaceuticals Segment 24

    Strength - Operational Efficiency 24

    Jubilant Life Sciences Limited - Weaknesses 25

    Weakness - Declining Performance of Life Sciences Ingredients Segment 25

    Jubilant Life Sciences Limited - Opportunities 26

    Opportunity - New Agreements 26

    Opportunity - Regulatory Approvals 26

    Opportunity - Vertically Integrated Operations 26

    Jubilant Life Sciences Limited - Threats 27

    Threat - Intense Competition 27

    Threat - Industry Consolidation 27

    Threat - Stringent Industry Regulations 27

    Jubilant Life Sciences Limited - Key Competitors 28

    Section 3 – Company Financial Ratios 29

    Financial Ratios - Capital Market Ratios 29

    Financial Ratios - Annual Ratios 30

    Performance Chart 32

    Financial Performance 32

    Financial Ratios - Interim Ratios 33

    Financial Ratios - Ratio Charts 34

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 35

    Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 35

    Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 36

    Jubilant Life Sciences Limited, Recent Deals Summary 37

    Section 5 – Company’s Recent Developments 38

    May 24, 2016: Jubilant Life Sciences announces board changes 38

    May 24, 2016: Jubiliant life sciences reports Q4 & FY 2016 results 39

    Mar 29, 2016: Jubilant Innovation Receives Upfront Payment and Potential Milestones from Its Investment 40

    Feb 19, 2016: Jubilant Reports Strong Profitability Q3 FY2016 EBITDA at Rs. 310 Crore, UP 62% YOY and PAT at Rs. 117 Crore 41

    Feb 06, 2016: Ministry of Commerce China has reduced the Anti-Dumping Duty on Pyridine from Jubilant to 17.6% 43

    Aug 11, 2015: Jubilant Life Sciences: Financial Results for the quarter ended June 30, 2015 44

    Jun 12, 2015: Jubilant’s Spokane facility successfully concludes inspection status 45

    May 12, 2015: Jubilant Life Sciences – Q4 & FY 2015 Results 46

    Feb 03, 2015: Jubilant Life Sciences- Q3 & 9M FY2015 Results 47

    Jan 06, 2015: Appointment of Mr. GP Singh as CEO - Jubilant Pharma 48

    Section 6 – Appendix 49

    Methodology 49

    Ratio Definitions 49

    About GlobalData 53

    Contact Us 53

    Disclaimer 53

List Of Tables
in Jubilant Life Sciences Limited - Financial and Strategic SWOT Analysis Review

List of Tables

Jubilant Life Sciences Limited, Key Facts 6

Jubilant Life Sciences Limited, Key Employees 7

Jubilant Life Sciences Limited, Key Employee Biographies 8

Jubilant Life Sciences Limited, Major Products and Services 9

Jubilant Life Sciences Limited, History 11

Jubilant Life Sciences Limited, Other Locations 18

Jubilant Life Sciences Limited, Subsidiaries 19

Jubilant Life Sciences Limited, Joint Venture 21

Jubilant Life Sciences Limited, Key Competitors 28

Jubilant Life Sciences Limited, Ratios based on current share price 29

Jubilant Life Sciences Limited, Annual Ratios 30

Jubilant Life Sciences Limited, Interim Ratios 33

Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 35

Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 36

Jubilant Life Sciences Limited, Recent Deals Summary 37

Currency Codes 49

Capital Market Ratios 49

Equity Ratios 50

Profitability Ratios 50

Cost Ratios 51

Liquidity Ratios 51

Leverage Ratios 52

Efficiency Ratios 52

List Of Figures, Charts and Diagrams
in Jubilant Life Sciences Limited - Financial and Strategic SWOT Analysis Review

List of Figures

Jubilant Life Sciences Limited, Performance Chart (2012 - 2016) 32

Jubilant Life Sciences Limited, Ratio Charts 34

Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 35

Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 36

Additional Details

Publisher

Global Data

Publisher Information

Reference

13494 | GDPH22222FSA

Number of Pages

53

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Jubilant Biosys Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryJubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provi...
06 Dec 2018 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Jubilant Life Sciences Limited (JUBILANT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryJubilant Life Sciences Limited (Jubilant) is an integrated pharmaceutical and life sciences c...
24 Aug 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Jubilant Biosys Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryJubilant Biosys Ltd. (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Limited is a d...
11 May 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Jubilant Life Sciences Limited (JUBILANT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryJubilant Life Sciences Limited (Jubilant), formerly Jubilant Organosys Limited, is an integra...
15 Apr 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Jubilant Life Sciences Limited (formerly known as Jubilant Organosys, Ltd.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $298 (normally
USD $351)
More Info
SAVE 15% today! Jubilant Biosys, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $298 (normally
USD $351)
More Info
SAVE 15% today! Jubilant Biosys Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryJubilant Biosys Ltd. (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Limited is a d...
14 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Jubilant Life Sciences Limited (JUBILANT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryJubilant Life Sciences Limited (Jubilant), formerly Jubilant Organosys Limited, is an integra...
08 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review provides yo...
20 Oct 2015 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Jubilant DraxImage Inc. - Medical Equipment - Deals and Alliances Profile
SummaryJubilant DraxImage Inc. (DraxImage) a subsidiary of Jubilant Life Sciences Limited is a nucle...
16 Oct 2015 by Global Data USD $213 (normally
USD $251)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...